Do Laxatives Help With Gastroparesis?

Traditional laxatives do not treat gastroparesis itself, which is a disorder of delayed stomach emptying, not a colon problem. But the two conditions overlap far more than most people realize, and treating the constipation that frequently accompanies gastroparesis can meaningfully improve a patient’s overall symptom burden. Roughly a third of gastroparesis patients experience severe constipation, and the relationship between sluggish stomach motility and sluggish bowel motility is more than coincidence. The practical question isn’t really whether laxatives “help gastroparesis” but rather how to address the whole-gut slowdown that many gastroparesis patients live with.

Why Gastroparesis and Constipation Travel Together

Gastroparesis is defined by delayed gastric emptying in the absence of a physical blockage, and its hallmark symptoms are nausea, vomiting, and abdominal pain.¹ Those are stomach symptoms, and the medications designed to speed up gastric emptying (called prokinetics) target the stomach specifically. So on the surface, a laxative that works in the colon seems irrelevant.

The reality is messier. The same nerve and muscle dysfunction that slows the stomach often affects the small intestine and colon too. One study using wireless motility capsules and radiopaque marker studies found that patients with confirmed gastroparesis had slow transit constipation at more than double the rate of patients who had gastroparesis-like symptoms but normal gastric emptying.² Patients with the most severe gastroparesis, defined as keeping more than 35% of a test meal in the stomach after four hours, were especially likely to also have slow-transit constipation.³

A large analysis of patients with gastroparesis symptoms found that about a third rated their constipation as severe or very severe, and another quarter called it moderate.⁴ Interestingly, constipation severity tracked with overall gastroparesis symptom severity and with transit times through the small bowel and colon, but it did not track with how delayed gastric emptying was on testing. That distinction matters: the constipation appears to be part of a broader motility disorder rather than a direct consequence of the stomach being slow.

What Laxatives Can and Cannot Do

If you have gastroparesis and you’re also constipated, a laxative can address the constipation. That might sound like stating the obvious, but many patients with gastroparesis are told their symptoms are “all stomach” and never have their bowel function properly evaluated. In a registry of over 1,000 gastroparesis patients, constipation medications were being used by about 45% of the total group, and among the small subset whose most bothersome symptom was constipation, that number jumped to 79%.⁵ Constipation medications are clearly a routine part of gastroparesis management in clinical practice, even if they aren’t treating the delayed gastric emptying itself.

What laxatives cannot do is speed up gastric emptying. Osmotic laxatives like polyethylene glycol (MiraLAX) pull water into the colon to soften stool. Stimulant laxatives like bisacodyl or senna trigger contractions in the colon wall. Neither type reaches the stomach in a meaningful way. If your primary gastroparesis symptoms are nausea, vomiting, and early fullness, a laxative alone won’t address those. But if backed-up bowels are adding to your bloating and discomfort, clearing the downstream traffic jam can take some pressure off the whole system.

The Fiber Problem

Fiber is the most common over-the-counter approach to constipation, and it’s where gastroparesis patients run into trouble. Dietary guidelines for gastroparesis generally recommend reducing fiber intake, because indigestible plant material sits in a sluggish stomach and can worsen nausea, bloating, and even contribute to bezoar formation (a mass of undigested material). That creates an obvious tension: fiber helps constipation but may aggravate the stomach.

A small pilot study tested whether a low-viscosity soluble fiber (partially hydrolyzed guar gum) could thread this needle, comparing it against psyllium husk, which is a high-viscosity fiber. Psyllium significantly increased nausea-related symptoms compared to water, which was expected given its thick, gel-forming properties. The low-viscosity fiber also appeared to increase nausea in some patients, though the result was not statistically significant and varied widely between individuals.⁶ The takeaway is that even supposedly gentle fiber supplements can be a gamble when your stomach isn’t emptying properly.

For gastroparesis patients dealing with constipation, osmotic laxatives or low-dose stimulant laxatives are generally better tolerated than fiber-based bulking agents. They work in the colon rather than needing to pass through the stomach intact, which sidesteps the nausea issue. That said, this is an area where individual tolerance varies enormously, and starting at low doses to gauge your response is the practical move.

Prokinetics and Why They Aren’t Laxatives

The medications most commonly prescribed to treat gastroparesis directly are prokinetics, which stimulate coordinated muscle contractions in the digestive tract. These include metoclopramide (the only drug with specific approval for gastroparesis in many countries), domperidone, and erythromycin used at low doses for its gut-stimulating side effect.⁷ Prokinetics work on the stomach’s motility machinery through specific receptor pathways, which is fundamentally different from how a laxative works in the colon.

The distinction gets blurred by one drug in particular: prucalopride. Prucalopride is approved for chronic constipation that hasn’t responded to traditional laxatives, making it sound like a laxative alternative. But it’s actually a prokinetic, working through serotonin receptors that influence motility throughout the gut, including the stomach. In a small study of 15 gastroparesis patients (mostly with diabetes), prucalopride at 4 mg accelerated gastric emptying and increased stool frequency. However, it did not appear to improve the core gastroparesis symptoms like nausea and poor appetite.⁸ So prucalopride sits in an interesting middle ground: it can address both slow gastric emptying and constipation mechanistically, but improving the numbers on a gastric emptying test doesn’t always translate into feeling better.

This gap between measurable improvement and symptomatic relief is one of the frustrating features of gastroparesis treatment in general. A medication might speed up stomach emptying on a test and still not reduce nausea or vomiting. It’s one of the reasons treatment tends to be symptom-directed rather than aiming at a single target.

How Treatment Tends to Be Layered in Practice

Because gastroparesis rarely shows up as a single clean symptom, treatment usually involves addressing several problems simultaneously. A patient whose worst symptom is nausea might be on an antiemetic. Someone whose worst symptom is vomiting might get a prokinetic. And someone struggling mainly with constipation gets constipation-directed treatment. That registry of over 1,000 patients showed this pattern clearly: antiemetics were used in about 59% of all patients, prokinetics in about 46%, and constipation medications in about 45%.⁵ The numbers tell you that most gastroparesis patients are on more than one category of drug.

What this means practically is that if you have gastroparesis and constipation, there’s nothing contradictory about being on both a prokinetic for the stomach and a laxative for the bowel. They address different parts of the same broad problem. The mistake would be taking a laxative and expecting it to replace a prokinetic, or assuming that because your gastroparesis is being treated, your constipation will resolve on its own. For many patients, it won’t, precisely because the motility dysfunction extends beyond the stomach.

Diabetic Gastroparesis and Blood Sugar Complications

Gastroparesis is especially common in people with longstanding diabetes, typically appearing alongside other complications like peripheral neuropathy and retinopathy. High blood sugar itself can temporarily slow gastric emptying even in healthy people, but true diabetic gastroparesis reflects nerve damage from years of poorly controlled glucose levels.⁹ The unpredictable gastric emptying then makes blood sugar harder to manage, because insulin timing no longer aligns with when food actually enters the intestine and gets absorbed. It’s a vicious cycle.

For people in this situation, constipation adds another layer of complexity. Certain diabetes medications, particularly opioid-based pain treatments sometimes prescribed for diabetic neuropathy, can worsen constipation. And the newer GLP-1 receptor agonists used for diabetes and weight management (drugs like semaglutide and tirzepatide) have their own complicated relationship with gut motility. Nausea, vomiting, constipation, and gastroparesis-like symptoms are among the most frequently reported side effects of these medications, though they are generally dose-dependent and tend to improve over time.¹⁰ If you’re on a GLP-1 drug and developing new constipation or worsening gastroparesis symptoms, that’s worth flagging to your doctor before simply reaching for a laxative, because the medication itself may need adjusting.

When Constipation Masks Something More

One nuance that clinicians look for is whether the constipation is genuinely slow-transit (the colon is mechanically sluggish) or is related to pelvic floor dysfunction, where the muscles involved in defecation aren’t coordinating properly. Both can coexist with gastroparesis, but they call for different treatments. Standard laxatives help with slow-transit constipation. Pelvic floor dysfunction responds better to biofeedback therapy and specialized physical therapy. If you’ve been taking laxatives for constipation alongside gastroparesis and they aren’t helping, the problem might not be that your bowels are too slow but rather that the exit mechanism isn’t working correctly.

The severity of constipation in gastroparesis patients was also associated with the presence of irritable bowel syndrome (IBS) in the large analysis mentioned earlier.⁴ IBS-constipation has its own treatment pathways, including medications like linaclotide and lubiprostone that work through different mechanisms than standard osmotic or stimulant laxatives. Teasing apart what’s gastroparesis, what’s slow-transit constipation, and what’s IBS can be genuinely difficult, but it changes which treatments are likely to help.

Beyond Medications for Refractory Cases

Some patients with gastroparesis don’t respond adequately to prokinetics, dietary changes, or symptom-directed medications including laxatives. For these refractory cases, procedural and device-based options have been expanding. A systematic review and network meta-analysis comparing the available interventions found that all of them, including dietary changes, drugs, botulinum toxin injection, gastric electrical stimulation, pyloroplasty, and a newer endoscopic procedure called G-POEM (gastric peroral endoscopic myotomy), showed significant short-term symptom improvement. G-POEM had the greatest short-term effect and also improved gastric emptying on testing. At intermediate follow-up of three months to three years, gastric electrical stimulation showed the highest efficacy.¹¹

G-POEM involves cutting the pyloric muscle at the stomach’s exit to allow food to pass more freely, and a separate review concluded that current evidence suggests it performs favorably compared to both gastric electrical stimulation and surgical pyloroplasty.¹² Research is still sorting out which procedure works best for which patients, and direct head-to-head comparisons between gastric electrical stimulation and pyloric-directed procedures are being planned to clarify the treatment algorithm.¹³

None of these interventions are laxatives, of course. But they matter to the laxative question because if you can successfully treat the root gastroparesis, downstream constipation sometimes improves too. And if your constipation persists even after gastroparesis treatment has improved gastric emptying, that confirms the constipation is part of the broader motility disorder rather than a simple downstream consequence, which means it needs its own targeted treatment regardless.

Practical Considerations for Managing Both Problems

If you have gastroparesis and constipation and are trying to figure out whether laxatives belong in your treatment plan, a few practical points are worth keeping in mind:

Osmotic over bulk-forming: Osmotic laxatives like polyethylene glycol are generally better tolerated than fiber supplements in gastroparesis, because they don’t add indigestible bulk to a stomach that’s already struggling to empty.
Stimulant laxatives as needed: Short-term use of stimulant laxatives like bisacodyl can help, but daily long-term use is something to discuss with your gastroenterologist, especially given the already-disrupted motility patterns.
Timing with meals: Taking a laxative on an empty stomach or well after eating may reduce the chance of it worsening nausea, though this varies by individual and by laxative type.
Hydration matters more: Dehydration is common in gastroparesis due to nausea-related poor intake and sometimes vomiting. Osmotic laxatives work by drawing water into the colon, so they can worsen dehydration if fluid intake is already low. Staying well-hydrated makes laxatives both safer and more effective.

The relationship between gastroparesis and constipation reinforces a broader point about gut motility disorders: the digestive tract works as a connected system, and a problem at one level often signals problems elsewhere. Treating constipation won’t fix gastroparesis, but ignoring it while focusing exclusively on the stomach means missing a major source of discomfort for many patients. For roughly a third of people with gastroparesis symptoms, constipation is severe enough to warrant its own treatment, and laxatives are a legitimate and commonly used part of that treatment.⁴